Close Menu

NEW YORK (GenomeWeb News) – EMD Millipore today announced that it has signed an agreement to acquire Seattle-based Amnis, a developer and manufacturer of high-speed cellular imaging instruments.

Amnis' technology is used for flow cytometry applications in academic, biotech, and pharmaceutical cell analysis and research. The acquisition complements EMD Millipore's existing Guava product offerings.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.